Mason Street Advisors, LLC Supernus Pharmaceuticals, Inc. Transaction History

Mason Street Advisors, LLC

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 May 14, 2021	SELL	$24.15 - $31.45 $474,450 - $617,866	-19,646 Closed	0 $0
Q4 2020 Feb 12, 2021	SELL	$17.7 - $25.81 $1,982 - $2,890	-112 Reduced 0.57%	19,646 $494,000
Q3 2020 Nov 13, 2020	BUY	$20.2 - $25.05 $666 - $826	33 Added 0.17%	19,758 $412,000
Q2 2020 Aug 14, 2020	BUY	$17.09 - $24.89 $24,814 - $36,140	1,452 Added 7.95%	19,725 $468,000
Q4 2019 Feb 19, 2020	BUY	$19.93 - $29.13 $9,247 - $13,516	464 Added 2.61%	18,273 $433,000
Q3 2019 Nov 05, 2019	BUY	$25.47 - $33.37 $8,226 - $10,778	323 Added 1.85%	17,809 $489,000
Q2 2019 Aug 12, 2019	BUY	$29.96 - $38.87 $20,462 - $26,548	683 Added 4.06%	17,486 $579,000
Q1 2019 May 07, 2019	BUY	$32.77 - $41.99 $18,842 - $24,144	575 Added 3.54%	16,803 $589,000
Q4 2018 Feb 13, 2019	BUY	$30.84 - $49.51 $23,345 - $37,479	757 Added 4.89%	16,228 $539,000
Q3 2018 Nov 13, 2018	BUY	$42.7 - $56.55 $21,947 - $29,066	514 Added 3.44%	15,471 $779,000
Q2 2018 Aug 14, 2018	BUY	$44.1 - $59.85 $29,106 - $39,501	660 Added 4.62%	14,957 $895,000
Q1 2018 May 14, 2018	BUY	$37.15 - $46.9 $35,812 - $45,211	964 Added 7.23%	14,297 $655,000
Q4 2017 Feb 14, 2018	BUY	$36.4 - $42.6 $17,945 - $21,001	493 Added 3.84%	13,333 $531,000
Q3 2017 Nov 13, 2017	BUY	$36.75 - $49.65 $471,870 - $637,506	12,840	12,840 $514,000

282

60.9M

27.7K

11.3K

Ticker SUPN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 53,495,300
Market Cap $1.93B
Description
Supernus Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of products for the treatment of central nervous system (CNS) diseases in the United States. Its commercial products are Trokendi XR, an extended release topiramate product indicated for the treatment of epilepsy, as well as for the prop...

Get notified when there are updates to the investment portfolio of Mason Street Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Mason Street Advisors, LLC with notifications on news.